ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: GM Cancer Research Foundation Awards Three Prizes to Five Cancer Researchers

May 5, 2000

Experts Call For Large International Study Of Mammography Screening In Ages 40-42

October 15, 1993

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer

November 29, 2002

Thompson Tours Brown’s Brain Science Center.

March 16, 2001